Hip Reconstruction Devices Market Research Report Information By Product Type (Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Hip Resurfacing Devices, Other), End-User (Hospitals, Orthopedic Clinics, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2032

Global Hip Reconstruction Devices Market Overview

Hip Reconstruction Devices Market Size was valued at USD 7.5 Billion in 2022. The Hip Reconstruction Devices Market industry is projected to grow from USD 8.0 Billion in 2023 to USD 13.78 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.00% during the forecast period (2024 - 2032). The increasing prevalence of infectious diseases and cancer, a growing demand for personalized medication, and advancements in molecular diagnostics technologies are expected to be significant market drivers for the Hip Reconstruction Devices Market.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Hip Reconstruction Devices Market Trends

• Increasing incidences of hip fractures, hip osteoarthritis, and the expanding geriatric population are driving the market growth

Market CAGR for Hip Reconstruction Devices is being driven by the increasing incidences of hip fractures, hip osteoarthritis, and the expanding geriatric population. The rising incidence of hip fractures and hip osteoarthritis is expected to drive the demand for hip reconstruction surgeries, addressing hip injuries, pain, and related symptoms. Notably, a study in the Irish Journal of Medical Science (April 2022) reported a 12.88% increase in hip fractures in Ireland in 2021. OECD statistics for 2023 revealed a significant number of hip replacement procedures, with over 46,368 and 13,815 performed in Turkey and Denmark, respectively, in 2021. The escalating cases of hip fractures are anticipated to fuel the demand for hip reconstruction surgeries, thereby contributing to the growth of hip reconstruction devices.

Furthermore, the expanding geriatric population is a key factor influencing the hip reconstruction devices market. Elderly individuals face a heightened risk of developing hip osteoarthritis and experiencing hip injuries, necessitating hip reconstruction surgery for effective management. Eurostat data from 2022 indicates a continuous increase in the percentage of individuals aged 65 years and above in the European Union. In 2021, this demographic comprised 20.7% of the total population, rising to 21.0% in France and from 19.8% to 20.1% in Spain in 2022. With the growing elderly population and the associated risk of hip-related issues, the demand for hip reconstruction surgeries is projected to surge, subsequently driving the market for hip replacement devices.

As a result, it is anticipated that throughout the projection period, demand for the Hip Reconstruction Devices Market will increase due to the increasing incidences of hip fractures, hip osteoarthritis, and the expanding geriatric population. Thus, driving the Hip Reconstruction Devices Market revenue.

Hip Reconstruction Devices Market Segment Insights

Hip Reconstruction Devices Market Product Type Insights

The Hip Reconstruction Devices Market segmentation, based on Product Type includes Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Hip Resurfacing Devices, and others. The Hip Resurfacing Devices segment dominated the market, accounting for 58% of market revenue. A study featured in Orthopaedics & Traumatology in February 2022 emphasized the favorable short-term outcomes of hip resurfacing surgeries, revealing minimal complications associated with metal-on-metal bearing surfaces. Drawing from data sourced from the French hip resurfacing registry, the study illustrated the enduring positive effects of hip resurfacing surgeries. Consequently, the anticipated increased adoption of hip resurfacing surgeries, leveraging the hip resurfacing device, is expected in the future for addressing hip pain, improving mobility, and addressing related issues. This projected trend is likely to drive greater demand for hip resurfacing devices in the future.

Hip Reconstruction Devices Market End-User Insights

The Hip Reconstruction Devices Market segmentation, based on End-User includes Hospitals, Orthopedic Clinics, and Others. The Orthopedic Clinics segment dominated the market, accounting for 58% of market revenue. The presence of skilled medical professionals and the accessibility of state-of-the-art medical equipment in these clinics are expected to drive the growth of the orthopedic clinics market.

Figure 1: Hip Reconstruction Devices Market, by End-User, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Hip Reconstruction Devices Market Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The anticipated expansion of the Hip Reconstruction Devices market in North America can be attributed to several key factors. The dominance of the North American market is attributed to the well-established reimbursement landscape for hip arthroplasty in the region. Additionally, the presence of advanced healthcare facilities and the increasing prevalence of obesity contribute to driving market growth. Obesity is identified as a significant risk factor for the development of osteoarthritis. For example, based on CDC statistics from 2020, the age-adjusted prevalence of obesity among adults in the United States was 42.4%, with the highest prevalence observed in adults aged 40-59 in the year 2017-2018. Furthermore, according to the 2018 Health Fact Sheets from Statistics Canada, approximately 26.8% of Canadians aged 18 and older, equivalent to roughly 7.3 million adults, were classified as obese. An additional 9.9 million adults (36.3%) were categorized as overweight, contributing to a total population with increased health risks due to excess weight reaching 63.1%.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: HIP RECONSTRUCTION DEVICES MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Hip Reconstruction Devices Market accounts for the second-largest market share as the market is witnessing growth propelled by the increasing incidence of hip fractures and cases of osteoarthritis. According to Ortho Consulting Group 2022, Western Europe has 57 million people affected by osteoarthritis out of a population of nearly 200 million. The number of individuals impacted by osteoarthritis has surged by 54 percent since 1990, with 91 percent of those affected reporting limitations in their normal activities. Furthermore, 43 percent of those affected are in the working-age group. One in five Europeans is undergoing long-term treatment for rheumatism and arthritis. In this region, the demand for hip reconstruction devices is also fueled by the rise in healthcare costs and increased public awareness of the benefits of hip replacement surgery. Further, the German Hip Reconstruction Devices Market held the largest market share, and the UK Hip Reconstruction Devices Market was the fastest-growing market in the European region.

The Asia-Pacific Hip Reconstruction Devices Market is expected to grow at the fastest CAGR from 2024 to 2032. The geriatric population, being at an elevated risk of hip fractures and hip osteoarthritis, is expected to drive market growth. According to the United Nations Population Fund in 2021, the population of older individuals (aged over 60) in the region is projected to triple between 2010 and 2050, reaching nearly 1.3 billion people. All these factors collectively contribute to the expanding market share of Asia-Pacific in the field of hip reconstruction devices. Moreover, China’s Hip Reconstruction Devices Market held the largest market share, and the Indian Hip Reconstruction Devices Market was the fastest-growing market in the Asia-Pacific region.

Hip Reconstruction Devices Market Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development to expand their product lines, which will help the Hip Reconstruction Devices market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Hip Reconstruction Devices industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Hip Reconstruction Devices industry to benefit clients and increase the market sector. In recent years, the Hip Reconstruction Devices industry has offered some of the most significant advantages to the healthcare sector and patients alike. Major players in the Hip Reconstruction Devices Market, including Zimmer Biomet, Johnson & Johnson, Stryker, Smith & Nephew, B. Braun Melsungen AG, Waldemar Link GmbH & Co. KG, Surgival, Exactech, Inc., LimaCorporate S.p.a., Microport, Hip Innovation Technology LLC, and JointMedica are attempting to increase market demand by investing in research and development operations.

Zimmer Biomet Holdings Inc (Zimmer Biomet) is a prominent medical device company specializing in musculoskeletal healthcare. The company is engaged in the design, manufacturing, and marketing of a wide range of products, including orthopedic reconstructive products, biologics, sports medicine, extremities, trauma products, integrated digital and robotic technologies, craniomaxillofacial and thoracic products, and office-based technologies. These offerings cater to the treatment of patients with bone, joint, and soft tissue disorders or injuries. Zimmer Biomet serves a diverse customer base, including orthopedic surgeons, neurosurgeons, specialists, distributors, hospitals, healthcare dealers, and purchasing organizations globally. The company operates through direct sales channels and distribution networks across the Americas, Europe, Asia-Pacific, the Middle East, and Africa. Headquartered in Warsaw, Indiana, USA, Zimmer Biomet recently entered into an exclusive partnership with OSSIS in July 2021 to serve as the distributor for their patient-specific 3D-printed titanium hip replacement joints in the Asia Pacific region.

Smith & Nephew Plc (Smith+Nephew) is a leading medical technology company specializing in the development, manufacturing, and marketing of medical devices across various healthcare segments, including orthopedic reconstruction and trauma, sports medicine, ENT, and advanced wound management. The company's product portfolio encompasses knee and hip implants for joint replacement, robotics-assisted technologies, trauma-related products for fracture stabilization, deformity correction procedures, soft tissue repair and removal instruments, and wound care products. Smith+Nephew serves a diverse customer base, including surgeons, nurses, physicians, general practitioners, and healthcare professionals in hospitals and insurance organizations. With a presence, the company markets its products in Europe, North America, Asia Pacific, the Middle East, and Africa. Headquartered in Watford, Hertfordshire, UK, Smith+Nephew strengthened its hip reconstruction device offerings by acquiring Integra LifeSciences' extremity orthopedics business for $240 million in 2020.

Key companies in the Hip Reconstruction Devices Market include

• Zimmer Biomet


• Johnson & Johnson


• Stryker


• Smith & Nephew


• B. Braun Melsungen AG


• Waldemar Link GmbH & Co. KG


• Surgival, Exactech, Inc.


• LimaCorporate S.p.a.


• Microport


• Hip Innovation Technology LLC


• JointMedica

Hip Reconstruction Devices Industry Developments

February 2023:In February 2023, the successful completion of the inaugural hip resurfacing procedure utilizing the innovative JointMedica polymotio hip implant was achieved through a collaborative effort by Exactech and JointMedica. The hip implant features a metal-on-polyethylene articulation.

January 2023:In January 2023, Hip Innovation Technology LLC commenced an FDA-approved investigational device exemption study, encompassing its HIT (hip innovation technology) reverse hip replacement system (Reverse HRS), operating under an FDA-approved investigational device exemption (IDE) in the United States.

Hip Reconstruction Devices Market Segmentation

Hip Reconstruction Devices Market Product Type Outlook

• 
  

   Primary Hip Reconstruction Devices

  
  


• 
  

  Partial Hip Reconstruction Devices

  
  


• 
  

  Hip Resurfacing Devices

  
  


• 
  

  Others

  
  

 Hip Reconstruction Devices Market End-User Outlook

• 
  

   Hospitals

  
  


• 
  

  Orthopedic Clinics

  
  


• 
  

  Others

  
  

Hip Reconstruction Devices Market Regional Outlook

• 
  

  North America

  
  

• 
  

  US

  
  


• 
  

  Canada

  
  

• 
  

  Europe

  
  

• 
  

  Germany

  
  


• 
  

  France

  
  


• 
  

  UK

  
  


• 
  

  Italy

  
  


• 
  

  Spain

  
  


• 
  

  Rest of Europe

  
  

• 
  

  Asia-Pacific

  
  
  
  
  • 
    

    China

    
    
  
  
  • 
    

    Japan

    
    
  
  
  • 
    

    India

    
    
  
  
  • 
    

    Australia

    
    
  
  
  • 
    

    South Korea

    
    
  
  
  • 
    

    Australia

    
    
  
  
  • 
    

    Rest of Asia-Pacific

    
    
  
  
  
  


• 
  

  Rest of the World

  
  
  
  
  • 
    

    Middle East

    
    
  
  
  • 
    

    Africa

    
    
  
  
  • 
    

    Latin America